• to reduced the chance of critical cardiovascular (heart and blood vessel) difficulties in Older people with style two diabetes and cardiovascular disease In October 2024, Novo Nordisk posted a study on scientific journal Nature a few novel glucose-sensitive insulin NNC2215 that will le